These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27984214)

  • 1. Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer.
    Suzuki Y; Okabayashi K; Hasegawa H; Tsuruta M; Shigeta K; Kondo T; Kitagawa Y
    Ann Surg; 2018 Mar; 267(3):527-531. PubMed ID: 27984214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer.
    Wang F; He W; Jiang C; Guo G; Ke B; Dai Q; Long J; Xia L
    BMC Cancer; 2018 Nov; 18(1):1102. PubMed ID: 30419863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer.
    Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
    Gastric Cancer; 2019 Mar; 22(2):403-412. PubMed ID: 29982861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
    Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection.
    Tokunaga R; Sakamoto Y; Nakagawa S; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H
    Int J Clin Oncol; 2017 Aug; 22(4):740-748. PubMed ID: 28213742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
    Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
    Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
    Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection.
    Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
    BMC Cancer; 2020 Jan; 20(1):11. PubMed ID: 31906893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Burden of Modified Glasgow Prognostic Scale in Colorectal Cancer.
    Okugawa Y; Shirai Y; Toiyama Y; Saigusa S; Hishida A; Yokoe T; Tanaka K; Tanaka M; Yasuda H; Fujikawa H; Hiro J; Kobayashi M; Araki T; Inoue Y; McMillan DC; Kusunoki M; Miki C
    Anticancer Res; 2018 Mar; 38(3):1599-1610. PubMed ID: 29491091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?
    Walsh SM; Casey S; Kennedy R; Ravi N; Reynolds JV
    J Surg Oncol; 2016 Jun; 113(7):732-7. PubMed ID: 27004839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic efficacy of preoperative mGPS, SIS and LCS in patients with gastric cancer.
    Chen YR; Chen YL; Ouyang SS; Xu HW; Li P; He LJ; Zhu SL
    Clin Chim Acta; 2020 Dec; 511():81-89. PubMed ID: 33002476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic inflammation score is a prognostic marker after curative resection in gastric cancer.
    Ma M; Weng M; Chen F; Hu Y; Lai J; Wang Y; Zhou Y
    ANZ J Surg; 2019 Apr; 89(4):377-382. PubMed ID: 30854753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases.
    Shimura T; Toiyama Y; Saigusa S; Imaoka H; Okigami M; Fujikawa H; Hiro J; Kobayashi M; Ohi M; Araki T; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    Int J Clin Oncol; 2017 Aug; 22(4):758-766. PubMed ID: 28299463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.
    Sun LC; Chu KS; Cheng SC; Lu CY; Kuo CH; Hsieh JS; Shih YL; Chang SJ; Wang JY
    BMC Cancer; 2009 Aug; 9():288. PubMed ID: 19691850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
    Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
    Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prediction Value of the Systemic Inflammation Score for Oral Cavity Squamous Cell Carcinoma.
    Eltohami YI; Kao HK; Lao WW; Huang Y; Abdelrahman M; Liao CT; Yen TC; Chang KP
    Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1042-1050. PubMed ID: 29336202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
    Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
    Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer.
    Otowa Y; Nakamura T; Takiguchi G; Tomono A; Yamamoto M; Kanaji S; Imanishi T; Suzuki S; Tanaka K; Itoh T; Kakeji Y
    Dis Esophagus; 2016; 29(2):146-51. PubMed ID: 25515972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.